Article 1 to 2 out of 2 concerning Acolyte Biomedica Ltd.
3M Expands its Medical Diagnostics Platform with Acquisition of Acolyte Biomedica Ltd.(19 Feb 2007) 3M announced it has acquired Acolyte Biomedica Ltd. Acolyte Biomedica brings to 3M's infection prevention platform a pipeline of rapid culture-based screening tests for microbes, such as MRSA and vancomycin-resistant enterococcus (VRE), that ...
Acolyte and Ploughshare Innovations Agree Exclusive Licence For Adenylate Kinase(13 Jun 2006) Acolyte Biomedica Ltd and Ploughshare Innovations Ltd have negotiated and agreed an exclusive global licence for the application of Adenylate Kinase (AK) in the fields of hygiene monitoring and clean-in-place monitoring of facilities, equipment and ...